A Standard Guideline for Albuterol Weaning in Pediatric Patients Admitted with an Asthma Exacerbation
The average length of stay for a pediatric asthma exacerbation in the United States is about 2.2 days; as nearly 1 in 50 children with asthma is hospitalized with an exacerbation each year, this creates a substantial burden for patients and their families. A critical determinant of length of stay is the patient ’s albuterol wean; however, providers' approaches to weaning patients vary widely. The purpose of this quality improvement project was to reduce patients’ lengths of stay by implementing a guideline for weaning albuterol.
Source: Journal of Allergy and Clinical Immunology - Category: Allergy & Immunology Authors: Max Collard, Leslie Bernal Charondo, Eric Kim, Mabel Chan Source Type: research
More News: Albuterol | Allergy | Allergy & Immunology | Asthma | Children | Pediatrics | Proair HFA | USA Health | Ventolin